The mastopexy market size is expected to see strong growth in the next few years. It will grow to $3.37 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to growing demand for body contouring procedures, increasing number of trained plastic surgeons, rising medical tourism for cosmetic surgeries, higher focus on post-pregnancy body restoration, expanding access to aesthetic procedures in emerging markets. Major trends in the forecast period include rising demand for cosmetic and aesthetic surgical procedures, increasing preference for combined breast lift and augmentation surgeries, growing acceptance of elective cosmetic surgery across age groups, rising focus on improved surgical outcomes and scar minimization, expansion of specialized aesthetic and plastic surgery clinics.
The increasing female geriatric population is anticipated to drive the growth of the mastopexy market in the coming years. The female geriatric population refers to women who are elderly, typically aged 65 years and above. This population is expanding due to longer life expectancy, advancements in healthcare that improve overall health outcomes, and declining birth rates in many countries. Mastopexy, or breast lift surgery, is increasingly sought by geriatric women to enhance breast shape and address age-related changes. For instance, in March 2025, according to Age UK, a UK-based charity, population aging is occurring worldwide. By 2050, women aged 65 years and above are projected to make up more than half (55%) of the global older population, which is estimated to reach 2 billion people aged 65 and over. The majority of this population will be concentrated in low- and middle-income countries. Consequently, the growing female geriatric population is contributing to the expansion of the mastopexy market.
The rising demand for cosmetic procedures is anticipated to drive the growth of the mastopexy market in the coming years. Cosmetic procedures are medical treatments or surgeries aimed at enhancing, modifying, or restoring an individual’s appearance. This growing demand is fueled by factors such as greater focus on personal appearance, advancements in minimally invasive technologies, and increased societal acceptance of aesthetic enhancements. Mastopexy assists in restoring the shape, firmness, and position of the breasts, addressing a common aesthetic concern and meeting the rising need for procedures that create youthful, firm, and well-contoured appearances, thereby supporting the growth of body contouring treatments. For example, in August 2023, The Aesthetic Society, a US-based organization for plastic surgery and cosmetic medicine, reported that Americans spent over $11.8 billion on aesthetic procedures overall, marking a 2% increase from the previous year. Consequently, the growing demand for cosmetic procedures is driving the expansion of the mastopexy market.
Major companies operating in the mastopexy market are concentrating on developing advanced products, such as nipple reconstruction solutions, to strengthen their competitive position in the market. Nipple reconstruction solutions involve surgical techniques and implants used to recreate the nipple-areola complex for patients who have undergone mastectomy or breast reconstruction surgery, with the goal of restoring a natural appearance and symmetry to the breast mound. These solutions frequently employ advanced materials and precise surgical methods to achieve realistic texture, projection, and aesthetic integration with the surrounding breast tissue. For example, in March 2024, GC Aesthetics, an Ireland-based medical technology company, launched the FixNip NRI, a nipple implant designed to transform breast reconstruction for women. This implant aims to enhance the standard of care in total breast reconstruction by providing a durable and natural-looking nipple-areola complex (NAC) reconstruction. Made from biocompatible, smooth silicone, the FixNip NRI incorporates a floral-shaped nitinol frame. This innovative design allows for minimal incisions and ensures the implant regains its original shape when folded and inserted.
Major companies operating in the mastopexy market are Spire Healthcare Group plc, Cynosure Inc., Silimed - Industria Ltda Implants, Establishment Labs Holdings Inc., Aurora Clinics, Mentor Worldwide LLC, Sientra Inc., GC Aesthetics, Sebbin SAS, Laboratoires Arion, Polytech Health & Aesthetics GmbH, Ideal Implant Incorporated, Surgiform Technology Ltd, The Esthetic Clinics, Olympus Cosmetic Group, Q Medical Industries, Guangzhou Wanhe Plastic Materials, Rau Plastic Surgery, Allergan Aesthetics, Motiva Implants.
North America was the largest region in the mastopexy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mastopexy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mastopexy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have had a limited impact on the mastopexy market, primarily affecting the cost of imported surgical instruments, sutures, and medical consumables. Specialty clinics and hospitals in regions dependent on imported devices, including parts of asia-pacific and europe, may experience moderate cost pressures. These increases can influence procedure pricing. However, tariffs also support local manufacturing of surgical tools and supplies, helping stabilize long-term availability.
The mastopexy market research report is one of a series of new reports that provides mastopexy market statistics, including mastopexy industry global market size, regional shares, competitors with a mastopexy market share, detailed mastopexy market segments, market trends and opportunities, and any further data you may need to thrive in the mastopexy industry. This mastopexy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Mastopexy, also referred to as a breast lift, is a surgical procedure designed to elevate and reshape sagging breasts. The procedure involves removing excess skin and tightening the surrounding tissue to achieve a more youthful breast contour. Mastopexy is frequently performed in combination with breast augmentation or reduction to attain the desired volume and shape.
The main types of mastopexy include the Benelli lift or donut lift, crescent breast lift, lollipop lift, and anchor breast lift. The Benelli lift, also called the donut lift, is a form of mastopexy that requires a circular incision around the areola (the darker skin surrounding the nipple). The tissue incisions involve skin, adipose, and glandular layers, and the procedure is performed by various end users, including hospitals and specialty clinics.
The mastopexy market consists of revenues earned by entities by providing services such as nipple repositioning, reshaping and lifting, incision techniques, and breast augmentation. The market value includes the value of related goods sold by the service provider or included within the service offering. The mastopexy market also includes sales of silicone breast implants, saline breast implants, and composite implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Mastopexy Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses mastopexy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for mastopexy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mastopexy market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Benelli Lift Or Donut Lift; Crescent Breast Lift; Lollipop Lift; Anchor Breast Lift2) By Tissue Incision: Skin; Adipose; Glandular
3) By End Use: Hospitals; Specialty Clinics
Subsegments:
1) By Benelli Lift Or Donut Lift: Periareolar Mastopexy; Circumareolar Mastopexy2) By Crescent Breast Lift: Partial Crescent Lift; Full Crescent Lift
3) By Lollipop Lift: Vertical Mastopexy; Single Vertical Incision Mastopexy
4) By Anchor Breast Lift: Inverted T Mastopexy; Wise Pattern Mastopexy
Companies Mentioned: Spire Healthcare Group plc; Cynosure Inc.; Silimed - Industria Ltda Implants; Establishment Labs Holdings Inc.; Aurora Clinics; Mentor Worldwide LLC; Sientra Inc.; GC Aesthetics; Sebbin SAS; Laboratoires Arion; Polytech Health & Aesthetics GmbH; Ideal Implant Incorporated; Surgiform Technology Ltd; The Esthetic Clinics; Olympus Cosmetic Group; Q Medical Industries; Guangzhou Wanhe Plastic Materials; Rau Plastic Surgery; Allergan Aesthetics; Motiva Implants
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Mastopexy market report include:- Spire Healthcare Group plc
- Cynosure Inc.
- Silimed - Industria Ltda Implants
- Establishment Labs Holdings Inc.
- Aurora Clinics
- Mentor Worldwide LLC
- Sientra Inc.
- GC Aesthetics
- Sebbin SAS
- Laboratoires Arion
- Polytech Health & Aesthetics GmbH
- Ideal Implant Incorporated
- Surgiform Technology Ltd
- The Esthetic Clinics
- Olympus Cosmetic Group
- Q Medical Industries
- Guangzhou Wanhe Plastic Materials
- Rau Plastic Surgery
- Allergan Aesthetics
- Motiva Implants
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.67 Billion |
| Forecasted Market Value ( USD | $ 3.37 Billion |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |


